Episodes
-
The Ellis Martin Report: Interview with International Stem Cell Corporation's Founder/Co-Chairman
TEMR: Welcome to The Ellis Martin Report. I’m Bob Lange. We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO. International Stem Cell Corporation has been one of the most exciting companies trading in the...
-
The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.
Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where I...
-
The Difference Between Adult Stem Cells and Embryonic Stem Cells
This is Ken Aldrich. I am Chairman of International Stem Cell Corporation and thought I’d talk for just a minute, or maybe a couple of minutes, about the different kinds of stem cells. People are always asking, “What’s the difference between an adult stem cell and an embryonic stem cell?” Let me...
-
International Stem Cell Corporation Offers a Possible Alternative to Animal Corneal Testing
Please take a moment to listen to International Stem Cell Corporation Chairman, Ken Aldrich, as he discusses the benefits of using human corneas developed in Petri dishes as an alternative to testing on the eyes of innocent rabbits. This is Ken Aldrich and I am chairman of International Stem Cell...
-
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO's parthenogenetic stem cell-derived human...
-
International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co
International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network. “To work with a company such as Millipore...
-
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three...
-
A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here
-
Meet Ken Aldrich the co-founder of International Stem Cell Corporation
Welcome to this podcast. I am Ken Aldrich, Chairman and co-founder of International Stem Cell Corporation. International Stem Cell Corporation recently announced that our scientific team, led by our Chief Scientist, Dr. Elena Revazova, has created a new class of human stem cell lines that do not...